Convergence insufficiency and excess

H7_CONVERGINSUFF

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H51.1
  • Cause of death: ICD-10 H51.1

2 out of 7 registries used, show all original rules.

530

4. Check minimum number of events

None

530

5. Include endpoints

None

530

6. Filter based on genotype QC (FinnGen only)

530

Control definitions (FinnGen only)

Control exclude
H7_OCUMUSCLE

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H51
Name in latin
Convergentia insufficiens sive nimia

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3911 2548 1357
Only index persons 3670 2423 1247
Unadjusted period prevalence (%)
Whole population 0.06 0.07 0.04
Only index persons 0.07 0.09 0.05
Median age at first event (years)
Whole population 19.34 21.03 16.06
Only index persons 20.89 22.48 17.81

-FinnGen-

Key figures

All Female Male
Number of individuals 530 410 120
Unadjusted period prevalence (%) 0.12 0.14 0.05
Median age at first event (years) 30.70 28.61 37.84

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
449
Matched controls
4488
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H51.1
ICD-10 Finland
Convergence insufficiency and excess
+∞
323.0
449
*
H53.3
ICD-10 Finland
Other disorders of binocular vision
308.2
99.0
97
*
H50.52
ICD-10 Finland
Exophoria
+∞
78.5
73
*
H53.2
ICD-10 Finland
Diplopia
36.6
43.1
55
17
H50.31
ICD-10 Finland
Intermittent exotropia
+∞
38.1
36
*
H50.1
ICD-10 Finland
Divergent concomitant strabismus
+∞
28.4
27
*
R51.80
ICD-10 Finland
Headache
3.6
24.9
135
482
XCW99
NOMESCO Finland
Other investigative procedure of eye
5.2
23.1
76
169
WX704
NOMESCO Finland
Intubation
5.3
21.2
68
146
SPAT1301
SPAT
No procedures
2.7
19.9
177
863
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.6
19.0
95
312
WX725
NOMESCO Finland
Noninvasive ventilation
7.0
18.7
47
74
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.4
18.1
99
347
CEC00
NOMESCO Finland
Recession of extraocular muscle
+∞
17.8
17
*
AA1AD
NOMESCO Finland
CT of head and brain
3.0
17.4
112
441
N03AX12
ATC
gabapentin; oral
3.3
17.3
98
349
WX720
NOMESCO Finland
Own respiration
7.2
17.3
42
63
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
4.5
17.0
63
157
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.8
15.9
123
538
N03AG01
ATC
valproic acid; systemic, rectal
4.4
15.6
58
145
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
+∞
14.7
14
*
H52.5
ICD-10 Finland
Disorders of accommodation
+∞
14.7
14
*
WX702
NOMESCO Finland
Supraglottic ventilation device
4.9
14.4
48
107
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.2
14.2
56
148
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
14.2
107
459
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
13.7
118
544
SPAT1324
SPAT
Screening procedure
2.4
13.5
137
691
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.6
13.5
63
194
SPAT1263
SPAT
Sampling
2.1
13.3
222
1410
H53.1
ICD-10 Finland
Subjective visual disturbances
4.5
12.9
46
111
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.1
12.8
51
136
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.1
12.5
74
271
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
5.8
12.4
35
65
A02BC03
ATC
lansoprazole; oral
2.3
12.1
132
687
H52.1
ICD-10 Finland
Myopia
11.0
11.9
22
21
R03AC02
ATC
salbutamol; inhalant
2.0
11.5
262
1845
SPAT1310
SPAT
Counselling related to known health issue
2.1
11.2
166
984
K07.60
ICD-10 Finland
Snapping jaw
3.7
10.6
46
133
H50.2
ICD-10 Finland
Vertical strabismus
+∞
10.5
10
*
37301
ICD-8 Finland
Strabismus, Concomitans divergens
+∞
10.5
10
*
H52.0
ICD-10 Finland
Hypermetropia
16.5
10.4
16
10
N01
ICPC
Headache
2.5
10.3
85
381
SPAT1097
SPAT
Recording of ECG
2.9
10.2
63
237
SPAT1260
SPAT
Consultation of another employee
2.4
10.1
89
412
UKC02
NOMESCO Finland
Cystoscopy
3.0
10.0
61
226
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.5
9.9
80
353
N06AX21
ATC
duloxetine; oral
2.8
9.9
67
264
N06AX11
ATC
mirtazapine; oral
2.0
9.6
148
878
H50.51
ICD-10 Finland
Esophoria
+∞
9.4
9
*
N06AA09
ATC
amitriptyline; systemic
3.2
9.0
48
164
WX400
NOMESCO Finland
Inhalation anesthesy
4.2
9.0
33
83
R03BA05
ATC
fluticasone; inhalant
2.2
8.9
104
550
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
8.8
154
951
SAA03
NOMESCO Finland
Extended examination of mouth
1.8
8.7
205
1405
R20.2
ICD-10 Finland
Paraesthesia of skin
3.2
8.5
45
153
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
8.5
183
1217
R44
ICPC
Respiratory, Preventive immunization/medic
13.1
8.4
14
11
H50.9
ICD-10 Finland
Strabismus, unspecified
+∞
8.4
8
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.9
8.3
51
188
SPAT1050
SPAT
Extensive neurological examination
7.3
8.3
19
27
M25.5
ICD-10 Finland
Pain in joint
1.9
8.3
137
826
HAMTE
NOMESCO Finland
NA
14.8
8.2
13
9
XA800
NOMESCO Finland
Neuropsychological investigation
3.9
8.1
32
86
A02BA02
ATC
ranitidine; systemic
2.4
8.1
72
333
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.5
8.1
23
44
SXA05
NOMESCO Finland
NA
10.3
8.1
15
15
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.6
8.0
60
253
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
11.1
7.8
14
13
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
7.8
46
168
TAB00
NOMESCO Finland
Lumbar puncture
3.5
7.8
35
105
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.1
7.8
29
74
XKC03
NOMESCO Finland
Water cystometry
5.6
7.6
21
39
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
25.5
7.6
10
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
10.3
7.6
14
14
A02BC05
ATC
esomeprazole; systemic
1.8
7.3
165
1101
CEC30
NOMESCO Finland
Resection of extraocular muscle
+∞
7.3
7
*
M54.4
ICD-10 Finland
Lumbago with sciatica
2.2
7.3
79
399
KMAK
NOMESCO Finland
NA
1.7
7.2
264
2035
-1
NOMESCO Finland
NA
1.7
7.2
184
1276
A45
ICPC
General and Unspecified, Observ/health educat/advice/diet
5.5
7.2
20
38
A04
ICPC
Weakness/tiredness general
2.2
7.1
70
341
XCK00
NOMESCO Finland
Perimetry
3.4
7.0
32
98
A02BC01
ATC
omeprazole; systemic
1.9
7.0
111
656
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
3.8
6.9
28
78
N05BA01
ATC
diazepam; systemic, rectal
2.4
6.9
59
267
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
4.1
6.9
25
63
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.5
6.9
30
89
R42
ICD-10 Finland
Dizziness and giddiness
2.1
6.8
82
432
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.3
6.8
66
319
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
6.7
89
488
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.0
6.7
38
134
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.6
6.7
49
204
N02AC04
ATC
dextropropoxyphene; oral
5.6
6.7
18
33
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
6.0
6.7
17
29
R06.0
ICD-10 Finland
Dyspnoea
2.0
6.6
92
517
N03AF02
ATC
oxcarbazepine; oral
4.5
6.4
21
48
R09
ICPC
Sinus symptom/complaint
2.3
6.4
58
268
F45.8
ICD-10 Finland
Other somatoform disorders
2.4
6.4
54
244
R03DC03
ATC
montelukast; oral
2.0
6.4
85
469
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.3
6.4
18
35
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.5
6.4
28
84
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.6
6.4
47
196
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
4.7
6.4
20
44
A01
ICPC
Pain general/multiple sites
2.8
6.4
40
151
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.8
6.3
38
142
XLD10
NOMESCO Finland
Gynaecological examination
11.2
6.3
11
10
H04.10
ICD-10 Finland
Dry eye syndrome
2.6
6.3
45
186
M03BX01
ATC
baclofen; systemic
7.2
6.3
14
20
H50.0
ICD-10 Finland
Convergent concomitant strabismus
+∞
6.3
6
*
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
3.7
6.2
25
70
H53.4
ICD-10 Finland
Visual field defects
7.8
6.2
13
17
F16
ICPC
Eyelid symptom/complaint
3.3
6.2
29
92
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
6.1
81
443
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.8
6.1
39
149
N05AH04
ATC
quetiapine; oral
2.0
6.1
88
498
C07AA05
ATC
propranolol; systemic
1.9
6.1
103
618
N03AX14
ATC
levetiracetam; systemic
5.0
6.1
18
37
C07AB07
ATC
bisoprolol; oral
1.7
6.0
135
890
R01AD01
ATC
beclometasone; nasal
2.0
6.0
73
389
SPAT1044
SPAT
Tympanometry
4.4
6.0
20
47

Mortality – FinRegistry

Association

Association between endpoint H7_CONVERGINSUFF and mortality.

Females

Parameter HR [95% CI] p-value
H7_CONVERGINSUFF 0.934 [0.75, 1.17] 0.547
Birth year 0.992 [0.98, 1.0] 0.087

During the follow-up period (1.1.1998 — 31.12.2019), 83 out of 2408 females with H7_CONVERGINSUFF died.

Males

Parameter HR [95% CI] p-value
H7_CONVERGINSUFF 1.371 [1.07, 1.76] 0.012
Birth year 0.989 [0.98, 1.0] 0.015

During the follow-up period (1.1.1998 — 31.12.2019), 112 out of 1274 males with H7_CONVERGINSUFF died.

Mortality risk

Mortality risk for people of age

years, who have H7_CONVERGINSUFF.

N-year risk Females Males
1 0.065% 0.274%
5 0.501% 1.774%
10 1.179% 4.347%
15 2.336% 8.311%
20 4.254% 13.689%

Relationships between endpoints

Index endpoint: H7_CONVERGINSUFF – Convergence insufficiency and excess

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data